ArticleHaematologica2020

LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA.

Audrey Belot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.